Studying the in vitro behavior of cationic solid lipid nanoparticles as a nonviral vector

Nanomedicine

Volumn 7, Issue 1, 2012, Pages 9-12

  Vighi, Eleonora ^a   Leo, Eliana ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

cationic lipids; gene delivery; nonviral vectors; solid lipid nanoparticles

Indexed keywords

CATIONIC SOLID LIPID NANOPARTICLE; NANOCARRIER; PLASMID DNA; SOLID LIPID NANOPARTICLE; UNCLASSIFIED DRUG;

GENE DELIVERY SYSTEM; GENETIC TRANSFECTION; NONHUMAN; NONVIRAL GENE THERAPY; PRIORITY JOURNAL; REVIEW; RNA INTERFERENCE; RNA VECTOR;

CATIONS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; LIPIDS; NANOPARTICLES; PLASMIDS;

EID: 84555190797     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.11.168     Document Type: Review

References (24)

1. McDonald D, Ildiko B, Shawn W et al. Advancing nonviral gene delivery: lipid-and surfactant-based nanoparticle design strategies. Nanomedicine 5, 1103-1127 (2010).
2. Wissing SA, Kayse O, Muller RH. Solid lipid nanoparticles for parenteral drug delivery. Adv. Drug Deliv. Rev. 56, 1257-1272 (2004). (Pubitemid 38510473)
3. Blasi P, Giovagnoli S, Schoubben A, Ricci M, Rossi C. Solid lipid nanoparticles for targeted brain drug delivery. Adv. Drug Deliv. Rev. 59, 454-477 (2007). (Pubitemid 47259226)
4. Harms M, Müller-Goymann CC. Solid lipid nanoparticles for drug delivery. Drug Del. Sci. Tech. 21, 89-99 (2011).
5. Gasco MR. Lipid nanoparticles: perspectives and challenges. Adv. Drug Deliv. Rev. 59, 377-378 (2007). (Pubitemid 47259229)
6. Bondi ML, Craparo EF. Solid lipid nanoparticles for applications in gene therapy: a review of the state of the art. Expert Opin. Drug Deliv. 7, 7-18 (2010).
7. Olbrich C, Bakowsky U, Lehr CM, Müller RH, Kneuer C. Cationic solid-lipid nanoparticles can effciently bind and transfect plasmid DNA. J. Control. Release 77, 345-355 (2001). (Pubitemid 33145485)
8. Vighi E, Ruozi B, Montanari M, Battini R, Leo E. Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: characterization and ability to bind the pEGFP-plasmid. Eur. J. Pharm. Biopharm. 67, 320-328 (2007). (Pubitemid 47211893)
9. Doktorovova S, Shegokar R, Rakovsky E et al. Cationic solid lipid nanoparticles (cSLN): structure, stability and DNA binding capacity correlation studies. Int. J. Pharm. 420, 341-349 (2011).
10. Rudolph C, Schillinger U, Ortiz A et al. Application of novel solid lipid nanoparticle (SLN)-gene vector formulations based on a dimeric HIV-1 TAT-peptide in vitro and in vivo. Pharm. Res. 21, 1662-1669 (2004). (Pubitemid 41184398)
11. Vighi E, Ruozi B, Montanari M, Battini R, Leo E. pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles. Int. J. Pharm. 389, 254-261 (2010).
12. Yu W, Liu C, Ye J, Zou W, Zhang N, Xu W. Novel cationic SLN containing a synthesized single-tailed lipid as a modifer for gene delivery. Nanotecnology 20, 102-112 (2009).
13. del Pozo-Rodriguez A, Pujals S, Delgado D et al. A proline-rich peptide improves cell transfection of solid lipid nanoparticle-based non viral-vectors. J. Control. Release 133, 52-59 (2009).
14. Morille M, Passirani C, Vonarbourg A, Clavreul A, Benoit JP. Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Biomaterials 29, 3477-3496 (2008).
15. Li X, Lin X, Zheng L et al. Effect of poly(ethylene glycol) stearate on the phase behavior of monocaprate/tween80/water system and characterization of poly(ethylene glycol) stearate-modifed solid lipid nanoparticles. Colloid Surf. A Physicochem. Eng. Aspects 317, 352-359 (2007).
16. Yu W, Liu C, Liu Y, Zhang N, Xu W. Mannan-modifed solid lipid nanoparticles for targeted gene delivery to alveolar macrophages. Pharm. Res. 27, 1584-1596 (2010).
17. Delgado D, del Pozo-Rodríguez A, Solinís MA, Rodríguez-Gascón A. Understanding the mechanism of protamine in solid lipid nanoparticle-based lipofection: the importance of the entry pathway. Eur. J. Pharm. Biopharm. 79, 495-502 (2011).
18. del Pozo-Rodriguez A, Delgado D, Solinis MA, Gascon AR, Pedrez JL. Solid lipid nanoparticles: formulation factors affecting cell transfection capacity. Int. J. Pharm. 339, 261-268 (2007). (Pubitemid 46977611)
19. Tiera MJ, Shi Q, Winnik FM, Fernandes JC. Polycation-based gene therapy: current knowledge and new perspectives. Curr. Gene Ther. 11, 288-306 (2011).
20. Choi SH, Jin SE, Lee MK et al. Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells. Eur. J. Pharm. Biopharm. 68, 545-554 (2008). (Pubitemid 351318200)
21. Vighi E, Montanari M, Ruozi B, Tosi G, Magli A, Leo E. Nuclear localization of cationic solid lipid nanoparticles containing Protamine as transfection promoter. Eur. J. Pharm. Biopharm. 76, 384-393 (2010).
22. Vighi E, Leo E, MontanariM, MucciA, Hanuskova M, Iannuccelli V. Structural investigation and intracellular traffcking of a novel multicomposite cationic SLN platform as pDNA carrier. Ther. Deliv. 2, 1419-1435 (2011).
23. Buse J, El-Aneed A. Properties, engineering and applications of lipid-based nanoparticle drug-delivery systems: current research and advances. Nanomedicine 5, 1237-1260 (2010).
24. Nimesh S, Gupta N, Chandra R. Strategies and advances in nanomedicine for targeted siRNA delivery. Nanomedicine (Lond.) 6(4), 729-746 (2011).